Existing investor Samsung Next returned for a $60m series C round as Healthy.io secured regulatory clearance for its app-based kidney disease test.
Israel-based medical device manufacturer Healthy.io completed a $60m series C round today backed by Samsung Next, an early-stage technology investment fund owned by electronics producer Samsung.
Venture capital firm Corner Ventures led the round while investment holding company Ansonia Holdings and VC firms Joy Capital and Aleph also took part.
Healthy.io has created an app-based version of the urine-albumin-to-creatinine-ratio (ACR) test, making it possible to detect conditions such as chronic kidney disease and urinary tract infections without the need for…
